These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 12927978)
1. Serovar determination, drug resistance patterns and plasmid profiles of Pseudomonas aeruginosa isolated from burn patients at two hospitals of Tehran (IRAN). Shahcheraghi F; Feizabadi MM; Yamin V; Abiri R; Abedian Z Burns; 2003 Sep; 29(6):547-51. PubMed ID: 12927978 [TBL] [Abstract][Full Text] [Related]
2. Characterization of Pseudomonas aeruginosa strains isolated from burned patients hospitalized in a major burn center in Tehran, Iran. Ranjbar R; Owlia P; Saderi H; Mansouri S; Jonaidi-Jafari N; Izadi M; Farshad S; Arjomandzadegan M Acta Med Iran; 2011; 49(10):675-9. PubMed ID: 22071644 [TBL] [Abstract][Full Text] [Related]
3. Plasmid-Mediated Quinolone Resistance in Pseudomonas aeruginosa Isolated from Burn Patients in Tehran, Iran. Molapour A; Peymani A; Saffarain P; Habibollah-Pourzereshki N; Rashvand P Infect Disord Drug Targets; 2020; 20(1):49-55. PubMed ID: 30727922 [TBL] [Abstract][Full Text] [Related]
4. Multidrug-resistant Pseudomonas aeruginosa strains harbouring R-plasmids and AmpC beta-lactamases isolated from hospitalised burn patients in a tertiary care hospital of North India. Shahid M; Malik A; Sheeba FEMS Microbiol Lett; 2003 Nov; 228(2):181-6. PubMed ID: 14638422 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility patterns and cross-resistance of antibiotics against Pseudomonas aeruginosa isolated from burn patients in the South of Iran. Japoni A; Alborzi A; Kalani M; Nasiri J; Hayati M; Farshad S Burns; 2006 May; 32(3):343-7. PubMed ID: 16527415 [TBL] [Abstract][Full Text] [Related]
6. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients. Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143 [TBL] [Abstract][Full Text] [Related]
7. Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients. Mirsalehian A; Feizabadi M; Nakhjavani FA; Jabalameli F; Goli H; Kalantari N Burns; 2010 Feb; 36(1):70-4. PubMed ID: 19524369 [TBL] [Abstract][Full Text] [Related]
8. Multiple-locus variable number of tandem repeats (VNTR) fingerprinting (MLVF) and antibacterial resistance profiles of extended spectrum beta lactamase (ESBL) producing Pseudomonas aeruginosa among burnt patients in Tehran. Jabalameli F; Mirsalehian A; Sotoudeh N; Jabalameli L; Aligholi M; Khoramian B; Taherikalani M; Emaneini M Burns; 2011 Nov; 37(7):1202-7. PubMed ID: 21703769 [TBL] [Abstract][Full Text] [Related]
9. [Investigation of acquired drug-resistant genes and strains relationship in Fan YF; Cui SY; Zhang C; Xu XM Zhonghua Shao Shang Za Zhi; 2018 Feb; 34(2):83-87. PubMed ID: 29973025 [No Abstract] [Full Text] [Related]
10. Pseudomonas infections in Tohid Burn Center, Iran. Rastegar Lari A; Bahrami Honar H; Alaghehbandan R Burns; 1998 Nov; 24(7):637-41. PubMed ID: 9882062 [TBL] [Abstract][Full Text] [Related]
11. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients. Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825 [TBL] [Abstract][Full Text] [Related]
12. Phenotypic and molecular detection of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates from patients with burns in Tehran, Iran. Azimi A; Peymani A; Pour PK Rev Soc Bras Med Trop; 2018; 51(5):610-615. PubMed ID: 30304266 [TBL] [Abstract][Full Text] [Related]
13. Antibiotic sensitivity and plasmid profiles of Pseudomonas aeruginosa. Igumbor E; Gwanzura L; Chirara M; Obi C; Muza D Cent Afr J Med; 2000 Nov; 46(11):296-300. PubMed ID: 12002119 [TBL] [Abstract][Full Text] [Related]
14. Pulsed field gel electrophoresis & plasmid profile of Pseudomonas aeruginosa at two hospitals in Tehran, Iran. Nikbin VS; Abdi-Ali A; Feizabadi MM; Gharavi S Indian J Med Res; 2007 Aug; 126(2):146-51. PubMed ID: 17932441 [TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of tobramycin, gentamicin, kanamycin, colistin, carbenicillin, and ticarcillin and clinical isolates of Pseudomonas aeruginosa: epidemiological and therapeutic implications. Dulong de Rosnay HL; Grimont PA; Dessaut B; Lesgouarres MT J Infect Dis; 1976 Aug; 134 Suppl():S50-6. PubMed ID: 823279 [TBL] [Abstract][Full Text] [Related]
16. Association between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in an intensive care burn unit: a 5-year study, 2000-2004. Messadi AA; Lamia T; Kamel B; Salima O; Monia M; Saida BR Burns; 2008 Dec; 34(8):1098-102. PubMed ID: 18619737 [TBL] [Abstract][Full Text] [Related]
17. The peculiarities of Pseudomonas aeruginosa resistance to antibiotics and prevalence of serogroups. Gailiene G; Pavilonis A; Kareiviene V Medicina (Kaunas); 2007; 43(1):36-42. PubMed ID: 17297282 [TBL] [Abstract][Full Text] [Related]
18. Frequency of Pseudomonas aeruginosa serotypes in burn wound infections and their resistance to antibiotics. Estahbanati HK; Kashani PP; Ghanaatpisheh F Burns; 2002 Jun; 28(4):340-8. PubMed ID: 12052372 [TBL] [Abstract][Full Text] [Related]
19. [Analysis of drug resistance of Pseudomonas aeruginosa and use of antibiotics in burn wards during 6 years]. Dou Y; Zhang Q Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):9-14. PubMed ID: 24684983 [TBL] [Abstract][Full Text] [Related]